These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11929813

  • 1. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM.
    Cancer Res; 2002 Apr 01; 62(7):1971-7. PubMed ID: 11929813
    [Abstract] [Full Text] [Related]

  • 2. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene.
    Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM.
    EMBO J; 1999 Nov 01; 18(21):5931-42. PubMed ID: 10545105
    [Abstract] [Full Text] [Related]

  • 3. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
    Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C.
    Cancer Res; 2001 Apr 15; 61(8):3245-9. PubMed ID: 11309273
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
    Boerboom D, White LD, Dalle S, Courty J, Richards JS.
    Cancer Res; 2006 Feb 15; 66(4):1964-73. PubMed ID: 16488995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T, Nakamura T, Kazuki Y, Oshimura M, Kohu K, Tago K, Ohwada S, Akiyama T.
    Cancer Res; 2002 Jun 01; 62(11):3322-6. PubMed ID: 12036951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y, Sills RC, Houle CD.
    Toxicol Pathol; 2005 Jun 01; 33(1):175-80. PubMed ID: 15805069
    [Abstract] [Full Text] [Related]

  • 13. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.
    Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C.
    Cancer Res; 1999 Aug 15; 59(16):3875-9. PubMed ID: 10463573
    [Abstract] [Full Text] [Related]

  • 14. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.
    Ogawa K, Yamada Y, Kishibe K, Ishizaki K, Tokusashi Y.
    Cancer Res; 1999 Apr 15; 59(8):1830-3. PubMed ID: 10213486
    [Abstract] [Full Text] [Related]

  • 15. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
    Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC.
    Oncogene; 1999 Aug 19; 18(33):4726-33. PubMed ID: 10467420
    [Abstract] [Full Text] [Related]

  • 16. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
    Kielman MF, Rindapää M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R.
    Nat Genet; 2002 Dec 19; 32(4):594-605. PubMed ID: 12426568
    [Abstract] [Full Text] [Related]

  • 17. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
    Zhuang SM, Wiseman RW, Söderkvist P.
    Oncogene; 2002 Aug 15; 21(36):5643-8. PubMed ID: 12165863
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.
    Kongkanuntn R, Bubb VJ, Sansom OJ, Wyllie AH, Harrison DJ, Clarke AR.
    Oncogene; 1999 Dec 02; 18(51):7219-25. PubMed ID: 10602475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.